INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 40.45 Billion by 2029 | 6.14 % | North America |
| By Resin Drugs | By Drugs | By Delivery Devices |
|---|---|---|
HI Drugs HI Delivery Devices |
Biologics Biosimilars |
Pens Pen Needles Syringes |
SCOPE OF THE REPORT
Human Insulin Market Overview
The human insulin market is expected to grow at 6.14 % CAGR from 2021 to 2029. It is expected to reach above USD 40.45 Billion by 2029 from USD 23.05 Billion in 2020.
A hormone produced by the pancreatic beta cells is insulin. It is essential for controlling glucose levels. It manages bodily functions and influences how amino acids are taken up by cells. aids in the blood’s absorption of glucose. A polygenic disorder is a medical illness when the patient has high glucose or blood sugar levels. Diabetes nephropathy and diabetic retinopathy are serious health problems brought on by this illness, which harms the glucose levels in blood tissues. One who has diabetes needs insulin every day since their body does not produce enough of it to keep their insulin levels under control.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), Volume (Thousand Units) |
| Segmentation | By Products, By Drugs, By Delivery Devices, By Diabetes Type, By Distribution Channel, By Brands, By Region |
| By Resin Drugs
 |
|
| By Drugs
 |
|
| By Delivery Devices
 |
|
| By Diabetes Type
 |
|
| By Distribution Channel |
|
| By Brands
 |
|
| By Region
 |
|
The market for human insulin drugs has been significantly impacted by the COVID-19 epidemic. Patients with type-1 diabetes are more affected by COVID-19. Since people with diabetes already have weakened immune systems, COVID-19 causes those immune systems to rapidly deteriorate. Compared to healthy persons, those with diabetes are more likely to experience significant complications.
Numerous health issues are related to diabetes. Diabetes patients spend more money on healthcare than non-diabetics because they have a 300% higher risk of being hospitalized than those without the disease. For the duration of the day, Type 2 diabetes patients need to make numerous adjustments to maintain normal blood glucose levels, such as taking additional insulin or eating more carbohydrates.
Additionally, patients who are trying to control their blood sugar levels to avoid the long-term consequences linked to swings in blood sugar levels are more likely to overcorrect and experience the ensuing hypoglycemia. As a result of the aforementioned variables, it is projected that the market under study will expand during the course of the investigation. The market for insulin is expanding as a result of things like rising diabetes rates and improvements in formulation also due to simple recognition of the condition and rising disease awareness.
The market for human insulin was significantly impacted by COVID-19. There were significant supply chain disruptions as a result of travel and cargo movement restrictions. Additionally, the production pace was reduced as a result of the temporary closure of manufacturing facilities to stop the virus’s spread. As a result, there was a brief global scarcity of human insulin. The market for human insulin, however, has recovered quickly since the COVID period.
Human Insulin Market Segment Analysis
The human insulin market is segmented based on products, drugs, delivery devices, diabetes type, distribution channel, brands and region, global trends and forecast.
On the basis of products, the market is segmented into hi drugs, hi delivery devices.
The market share with the highest projection belongs to the hi drugs segment. The factors include an older population that is becoming more prevalent in industrialized nations, increased drug research and development R&D, and rising market availability of generic human insulin products globally.
On the basis of drugs, the market is segmented into biologics, biosimilars.
The category for short-acting biologics is expected to witness the highest CAGR during the estimated period. Its delayed action and adaptability to the human body can be due to the reasons.
On the basis of delivery devices, the market is segmented into pens, pen needles, syringes.
Given its portability and ease, the pen-type insulin delivery device is becoming more and more well-liked. Some of the reasons driving the growth of this market include the expanding use of diabetes medications and the rising awareness of the illness. Pens are anticipated to hold the biggest market share for insulin in 2022, followed by pen needles. Due to their expanding use in clinical settings and ability to enhance the outcomes of diabetes treatment, syringes are anticipated to experience the greatest rate of growth over the projected period.
On the basis of diabetes type, the market is segmented into type 1 diabetes, type 2 diabetes.
During the projection period, the type 1 diabetes sector is anticipated to increase at the greatest rate. These individuals have a significant insulin dependence. It is a riskier illness than type 2 diabetes. According to the international diabetes federation, 10% of people with diabetes have type 1 diabetes. The subgroup with the fastest expected rate of growth is type 2 diabetes mellitus. It is the variety that is most prevalent globally. The main reason promoting the segment’s growth is its high prevalence.
On the basis of distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online retail stores.
During the projected period, the retail pharmacies segment is anticipated to increase at the highest rate. This market is flourishing as a result of the increased disease burden, the viability of patients receiving care at home, and the numerous discounts provided by retail pharmacies. In the American market, retail pharmacy chains have consolidated. It is also anticipated that the hospital pharmacy market will expand somewhat. The increase in diabetic individuals being admitted to hospitals is one of the factors driving this market segment.
On the basis of brands, the market is segmented into Lantus, Novorapid, Humalog, Insulatard, Humulin, Insuman.
The segment for today’s human insulin will increase at the fastest rate during the projection period. In the 1980s, the development of human insulin was hailed as a major achievement since it made it possible to produce vast quantities of insulin at low cost. Despite the lack of conclusive evidence to either confirm or refute this claim, reports have connected human insulins to adverse effects such hypoawareness, fatigue, and weight gain that are not often associated with animal insulins.
Human Insulin Market Players
Braun Melsungen AG, Becton, Dickinson and Company, Biocon Limited, Biodel Inc., ELI Lilly and Company, Julphar, NOVO Nordisk A/S, Sanofi, Boehringer Ingelheim International GmbH, United Laboratories International Holding Limited, Tonghua Dongbao Pharmaceutical Co. Ltd., BIOTON S.A., Gan & Lee Pharmaceuticals Co Ltd., Wockhardt Limited, Ypsomed AG., are the major Human Insulin market players.
12 September, 2022: Novo Nordisk and Microsoft collaborated to accelerate drug discovery and development using big data and artificial intelligence. Both entered into a new strategic collaboration to combine computational services, AI with drug development and data science capabilities.
19 December, 2022: Sanofi and Innate Pharma SA announced an expansion of their collaboration with Sanofi licensing a natural killer cell engager program targeting B7H3 from Innate’s ANKET platform.
Who Should Buy? Or Key stakeholders
- Healthcare Service Providers
- Research Laboratories and Academic Institutes
- Product Sales and Distribution Companies
- Original Equipment Manufacturers (OEMs)
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations (CROs)
- Research and Development Companies
- Non-government Organizations
Human Insulin Market Regional Analysis
The Human Insulin Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
In terms of revenue, North America was the dominant region in 2021, mostly because of the supremacy of branded goods and the region’s rising disease prevalence. In 2020, the CDC estimated that 37.3 million Americans had diabetes, of whom 28.7 million had been diagnosed and 8.5 million had not. Additionally, 96 million adults age 18 and older have prediabetes. Novo Nordisk A/S, Eli Lilly and Company, and Sanofi are a few of the main companies that are currently active in this area. However, Semglee and Rezvoglar, two new insulin biosimilars from Mylan/Biocon and Eli Lilly and Company, respectively, have received FDA approval in the United States. The introduction of these biosimilars is anticipated to lower the cost of insulin on the American market and intensify the competition.
Due to factors like growing geriatric and target populations, an increase in partnerships for the improvement of biosimilars, geographic growth of key players, and active involvement of the government and nonprofit sectors in the market space, Asia Pacific is predicted to experience significant growth during the forecast period. Additionally, regional market expansion may be aided by health outreach programs and scientific conferences for the treatment of this disease.
In terms of revenue, North America was the dominant region in 2021, mostly because of the supremacy of branded goods and the region’s rising disease prevalence. In 2020, the CDC estimated that 37.3 million Americans had diabetes, of whom 28.7 million had been diagnosed and 8.5 million had not. Additionally, 96 million adults age 18 and older have prediabetes. Novo Nordisk A/S, Eli Lilly and Company, and Sanofi are a few of the main companies that are currently active in this area. However, Semglee and Rezvoglar, two new insulin biosimilars from Mylan/Biocon and Eli Lilly and Company, respectively, have received FDA approval in the United States. The introduction of these biosimilars is anticipated to lower the cost of insulin on the American market and intensify the competition.
Due to factors like growing geriatric and target populations, an increase in partnerships for the improvement of biosimilars, geographic growth of key players, and active involvement of the government and nonprofit sectors in the market space, Asia Pacific is predicted to experience significant growth during the forecast period. Additionally, regional market expansion may be aided by health outreach programs and scientific conferences for the treatment of this disease.
In terms of revenue, North America was the dominant region in 2021, mostly because of the supremacy of branded goods and the region’s rising disease prevalence. In 2020, the CDC estimated that 37.3 million Americans had diabetes, of whom 28.7 million had been diagnosed and 8.5 million had not. Additionally, 96 million adults age 18 and older have prediabetes. Novo Nordisk A/S, Eli Lilly and Company, and Sanofi are a few of the main companies that are currently active in this area. However, Semglee and Rezvoglar, two new insulin biosimilars from Mylan/Biocon and Eli Lilly and Company, respectively, have received FDA approval in the United States. The introduction of these biosimilars is anticipated to lower the cost of insulin on the American market and intensify the competition.
Due to factors like growing geriatric and target populations, an increase in partnerships for the improvement of biosimilars, geographic growth of key players, and active involvement of the government and nonprofit sectors in the market space, Asia Pacific is predicted to experience significant growth during the forecast period. Additionally, regional market expansion may be aided by health outreach programs and scientific conferences for the treatment of this disease.
Key Market Segments: Human Insulin Market
Human Insulin Market By Products, 2020-2029, (Usd Billion, Thousand Units)
- Hi Drugs
- Hi Delivery Devices
Human Insulin Market By Drugs, 2020-2029, (Usd Billion, Thousand Units)
- Biologics
- Biosimilars
Human Insulin Market By Delivery Devices, 2020-2029, (Usd Billion, Thousand Units)
- Pens
- Pen Needles
- Syringes
Human Insulin Market By Diabetes Type, 2020-2029, (Usd Billion, Thousand Units)
- Type 1 Diabetes
- Type 2 Diabetes
Human Insulin Market By Distribution Channel, 2020-2029, (Usd Billion, Thousand Units)
- Retail Pharmacies
- Hospital Pharmacies
- Online Retail Stores
Human Insulin Market By Brands, 2020-2029, (Usd Billion, Thousand Units)
- Lantus
- Novorapid
- Humalog
- Insulatard
- Humulin
- Insuman
Human Insulin Market By Region, 2020-2029, (Usd Billion)
- North America
- Asia Pacific
- Europe
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Exactitude Consultancy Core Human Insulin Services Key Objectives:
- Increasing sales and market share
- Developing new Drugs
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the human insulin market over the next 7 years?
- Who are the major players in the human insulin market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the human insulin market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the human insulin market?
- What is the current and forecasted size and growth rate of the global human insulin market?
- What are the key drivers of growth in the human insulin market?
- What are the distribution channels and supply chain dynamics in the human insulin market?
- What are the technological advancements and innovations in the human insulin market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the human insulin market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the human insulin market?
- What are the product offerings and specifications of leading players in the market?
- What is the pricing trend of human insulin in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL HUMAN INSULIN MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON HUMAN INSULIN MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL HUMAN INSULIN MARKET OUTLOOK
- GLOBAL HUMAN INSULIN MARKET BY PRODUCT (USD BILLION, THOUSAND UNITS), 2020-2029
- HI DRUG
- HI DELIVERY DEVICES
- GLOBAL HUMAN INSULIN MARKET BY DRUG (USD BILLION, THOUSAND UNITS), 2020-2029
- BIOLOGICS
- BIOSIMILARS
- GLOBAL HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION, THOUSAND UNITS), 2020-2029
- PENS
- PEN NEEDLES
- SYRINGES
- GLOBAL HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION, THOUSAND UNITS), 2020-2029
- TYPE 1 DIABETES
- TYPE 2 DIABETES
- GLOBAL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION, THOUSAND UNITS), 2020-2029
- RETAIL PHARMACIES
- HOSPITAL PHARMACIES
- ONLINE RETAIL STORES
- GLOBAL HUMAN INSULIN MARKET BY BRAND (USD BILLION, THOUSAND UNITS), 2020-2029
- LANTUS
- NOVORAPID
- HUMALOG
- INSULATARD
- HUMULIN
- INSUMAN
- GLOBAL HUMAN INSULIN MARKET BY REGION (USD BILLION), 2020-2029
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCT OFFERED, RECENT DEVELOPMENTS)
- BRAUN MELSUNGEN AG
- BECTON, DICKINSON AND COMPANY
- BIOCON LIMITED
- BIODEL INC.
- ELI LILLY AND COMPANY
- JULPHAR
- NOVO NORDISK A/S
- SANOFI
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- UNITED LABORATORIES INTERNATIONAL HOLDING LIMITED
- TONGHUA DONGBAO PHARMACEUTICAL CO. LTD.
- BIOTON S.A.
- GAN & LEE PHARMACEUTICALS CO LTD.
- WOCKHARDT LIMITED
- YPSOMED AG. *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 2Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 3Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 4Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 5Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 6Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 7Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 8Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 9Â Â Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 10Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 11Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 12Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 13Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY REGION (USD BILLION) 2020-2029
TABLE 14Â Â Â Â Â GLOBAL HUMAN INSULIN MARKET BY REGION (THOUSAND UNITS) 2020-2029
TABLE 15Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 16Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 17Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 18Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 19Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 20Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 21Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 22Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 23Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 24Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 25Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 26Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 27Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 28Â Â Â Â Â NORTH AMERICA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 29Â Â Â Â Â US HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 30Â Â Â Â Â US HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 31Â Â Â Â Â US HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 32Â Â Â Â Â US HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 33Â Â Â Â Â US HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 34Â Â Â Â Â US HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 35Â Â Â Â Â US HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 36Â Â Â Â Â US HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 37Â Â Â Â Â US HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 38Â Â Â Â Â US HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 39Â Â Â Â Â US HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 40Â Â Â Â Â US HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 41Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 42Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 43Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 44Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 45Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 46Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 47Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 48Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 49Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 50Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 51Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 52Â Â Â Â Â CANADA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 53Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 54Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 55Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 56Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 57Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 58Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 59Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 60Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 61Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 62Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 63Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 64Â Â Â Â Â MEXICO HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 65Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 66Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 67Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 68Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 69Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 70Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 71Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 72Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 73Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 74Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 75Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 76Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 77Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 78Â Â Â Â Â SOUTH AMERICA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 79Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 80Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 81Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 82Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 83Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 84Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 85Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 86Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 87Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 88Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 89Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 90Â Â Â Â Â BRAZIL HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 91Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 92Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 93Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 94Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 95Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 96Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 97Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 98Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 99Â Â Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 100Â Â Â ARGENTINA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 101Â Â Â ARGENTINA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 102Â Â Â ARGENTINA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 103Â Â Â COLOMBIA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 104Â Â Â COLOMBIA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 105Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 106Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 107Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 108Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 109Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 110Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 111Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 112Â Â Â COLOMBIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 113Â Â Â COLOMBIA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 114Â Â Â COLOMBIA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 115Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 116Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 117Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 118Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 119Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 120Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 121Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 122Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 123Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 124Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 125Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 126Â Â Â REST OF SOUTH AMERICA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 127Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 128Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 129Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 130Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 131Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 132Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 133Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 134Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 135Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 136Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 137Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 138Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 139Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 140Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 141Â Â Â INDIA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 142Â Â Â INDIA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 143Â Â Â INDIA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 144Â Â Â INDIA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 145Â Â Â INDIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 146Â Â Â INDIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 147Â Â Â INDIA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 148Â Â Â INDIA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 149Â Â Â INDIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 150Â Â Â INDIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 151Â Â Â INDIA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 152Â Â Â INDIA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 153Â Â Â CHINA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 154Â Â Â CHINA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 155Â Â Â CHINA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 156Â Â Â CHINA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 157Â Â Â CHINA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 158Â Â Â CHINA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 159Â Â Â CHINA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 160Â Â Â CHINA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 161Â Â Â CHINA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 162Â Â Â CHINA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 163Â Â Â CHINA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 164Â Â Â CHINA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 165Â Â Â JAPAN HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 166Â Â Â JAPAN HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 167Â Â Â JAPAN HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 168Â Â Â JAPAN HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 169Â Â Â JAPAN HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 170Â Â Â JAPAN HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 171Â Â Â JAPAN HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 172Â Â Â JAPAN HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 173Â Â Â JAPAN HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 174Â Â Â JAPAN HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 175Â Â Â JAPAN HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 176Â Â Â JAPAN HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 177Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 178Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 179Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 180Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 181Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 182Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 183Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 184Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 185Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 186Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 187Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 188Â Â Â SOUTH KOREA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 189Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 190Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 191Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 192Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 193Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 194Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 195Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 196Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 197Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 198Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 199Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 200Â Â Â AUSTRALIA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 201Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 202Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 203Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 204Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 205Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 206Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 207Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 208Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 209Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 210Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 211Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 212Â Â Â SOUTH-EAST ASIA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 213Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 214Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 215Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 216Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 217Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 218Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 219Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 220Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 221Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 222Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 223Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 224Â Â Â REST OF ASIA PACIFIC HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 225Â Â Â EUROPE HUMAN INSULIN MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 226Â Â Â EUROPE HUMAN INSULIN MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 227Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 228Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 229Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 230Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 231Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 232Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 233Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 234Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 235Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 236Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 237Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 238Â Â Â ASIA-PACIFIC HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 239Â Â Â GERMANY HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 240Â Â Â GERMANY HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 241Â Â Â GERMANY HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 242Â Â Â GERMANY HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 243Â Â Â GERMANY HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 244Â Â Â GERMANY HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 245Â Â Â GERMANY HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 246Â Â Â GERMANY HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 247Â Â Â GERMANY HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 248Â Â Â GERMANY HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 249Â Â Â GERMANY HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 250Â Â Â GERMANY HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 251Â Â Â UK HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 252Â Â Â UK HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 253Â Â Â UK HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 254Â Â Â UK HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 255Â Â Â UK HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 256Â Â Â UK HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 257Â Â Â UK HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 258Â Â Â UK HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 259Â Â Â UK HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 260Â Â Â UK HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 261Â Â Â UK HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 262Â Â Â UK HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 263Â Â Â FRANCE HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 264Â Â Â FRANCE HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 265Â Â Â FRANCE HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 266Â Â Â FRANCE HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 267Â Â Â FRANCE HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 268Â Â Â FRANCE HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 269Â Â Â FRANCE HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 270Â Â Â FRANCE HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 271Â Â Â FRANCE HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 272Â Â Â FRANCE HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 273Â Â Â FRANCE HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 274Â Â Â FRANCE HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 275Â Â Â ITALY HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 276Â Â Â ITALY HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 277Â Â Â ITALY HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 278Â Â Â ITALY HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 279Â Â Â ITALY HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 280Â Â Â ITALY HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 281Â Â Â ITALY HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 282Â Â Â ITALY HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 283Â Â Â ITALY HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 284Â Â Â ITALY HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 285Â Â Â ITALY HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 286Â Â Â ITALY HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 287Â Â Â SPAIN HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 288Â Â Â SPAIN HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 289Â Â Â SPAIN HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 290Â Â Â SPAIN HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 291Â Â Â SPAIN HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 292Â Â Â SPAIN HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 293Â Â Â SPAIN HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 294Â Â Â SPAIN HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 295Â Â Â SPAIN HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 296Â Â Â SPAIN HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 297Â Â Â SPAIN HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 298Â Â Â SPAIN HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 299Â Â Â RUSSIA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 300Â Â Â RUSSIA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 301Â Â Â RUSSIA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 302Â Â Â RUSSIA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 303Â Â Â RUSSIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 304Â Â Â RUSSIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 305Â Â Â RUSSIA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 306Â Â Â RUSSIA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 307Â Â Â RUSSIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 308Â Â Â RUSSIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 309Â Â Â RUSSIA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 310Â Â Â RUSSIA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 311Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 312Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 313Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 314Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 315Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 316Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 317Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 318Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 319Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 320Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 321Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 322Â Â Â REST OF EUROPE HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 323Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY COUNTRY (USD BILLION) 2020-2029
TABLE 324Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY COUNTRY (THOUSAND UNITS) 2020-2029
TABLE 325Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 326Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 327Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 328Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 329Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 330Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 331Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 332Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 333Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 334Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 335Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 336Â Â Â MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 337Â Â Â UAE HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 338Â Â Â UAE HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 339Â Â Â UAE HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 340Â Â Â UAE HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 341Â Â Â UAE HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 342Â Â Â UAE HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 343Â Â Â UAE HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 344Â Â Â UAE HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 345Â Â Â UAE HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 346Â Â Â UAE HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 347Â Â Â UAE HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 348Â Â Â UAE HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 349Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 350Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 351Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 352Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 353Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 354Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 355Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 356Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 357Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 358Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 359Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 360Â Â Â SAUDI ARABIA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 361Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 362Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 363Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 364Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 365Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 366Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 367Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 368Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 369Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 370Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 371Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 372Â Â Â SOUTH AFRICA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
TABLE 373Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY PRODUCT (USD BILLION) 2020-2029
TABLE 374Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY PRODUCT (THOUSAND UNITS) 2020-2029
TABLE 375Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DRUG (USD BILLION) 2020-2029
TABLE 376Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DRUG (THOUSAND UNITS) 2020-2029
TABLE 377Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (USD BILLION) 2020-2029
TABLE 378Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DELIVERY DEVICES (THOUSAND UNITS) 2020-2029
TABLE 379Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DIABETES TYPE (USD BILLION) 2020-2029
TABLE 380Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DIABETES TYPE (THOUSAND UNITS) 2020-2029
TABLE 381Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (USD BILLION) 2020-2029
TABLE 382Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL (THOUSAND UNITS) 2020-2029
TABLE 383Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY BRAND (USD BILLION) 2020-2029
TABLE 384Â Â Â REST OF MIDDLE EAST AND AFRICA HUMAN INSULIN MARKET BY BRAND (THOUSAND UNITS) 2020-2029
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 RESEARCH FLOW
FIGURE 5 GLOBAL HUMAN INSULIN MARKET BY PRODUCT, USD BILLION, 2020-2029
FIGURE 6 GLOBAL HUMAN INSULIN MARKET BY DRUG, USD BILLION, 2020-2029
FIGURE 7 GLOBAL HUMAN INSULIN MARKET BY DELIVERY DEVICES, USD BILLION, 2020-2029
FIGURE 8 GLOBAL HUMAN INSULIN MARKET BY DIABETES TYPE, USD BILLION, 2020-2029
FIGURE 9 GLOBAL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL, USD BILLION, 2020-2029
FIGURE 10 GLOBAL HUMAN INSULIN MARKET BY BRAND, USD BILLION, 2020-2029
FIGURE 11 GLOBAL HUMAN INSULIN MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 12 PORTER’S FIVE FORCES MODEL
FIGURE 13 GLOBAL HUMAN INSULIN MARKET BY PRODUCT, USD BILLION, 2021
FIGURE 14 GLOBAL HUMAN INSULIN MARKET BY DRUG, USD BILLION, 2021
FIGURE 15 GLOBAL HUMAN INSULIN MARKET BY DELIVERY DEVICES, USD BILLION, 2021
FIGURE 16 GLOBAL HUMAN INSULIN MARKET BY DIABETES TYPE, USD BILLION, 2021
FIGURE 17 GLOBAL HUMAN INSULIN MARKET BY DISTRIBUTION CHANNEL, USD BILLION, 2021
FIGURE 18 GLOBAL HUMAN INSULIN MARKET BY BRAND, USD BILLION, 2021
FIGURE 19 GLOBAL HUMAN INSULIN MARKET BY REGION, USD BILLION, 2021
FIGURE 20 MARKET SHARE ANALYSIS
FIGURE 21 BIOTON S.A.: COMPANY SNAPSHOT
FIGURE 22 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 23 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 24 BIOCON LIMITED: COMPANY SNAPSHOT
FIGURE 25 BIODEL INC.: COMPANY SNAPSHOT
FIGURE 26 ELI LILLY AND COMPANY: COMPANY SNAPSHOT
FIGURE 27 JULPHAR: COMPANY SNAPSHOT
FIGURE 28 NOVO NORDISK A/S: COMPANY SNAPSHOT
FIGURE 29 SANOFI: COMPANY SNAPSHOT
FIGURE 30 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
FIGURE 31 UNITED LABORATORIES INTERNATIONAL HOLDING LIMITED: COMPANY SNAPSHOT
FIGURE 32 TONGHUA DONGBAO PHARMACEUTICAL CO. LTD.: COMPANY SNAPSHOT
FIGURE 33 GAN & LEE PHARMACEUTICALS CO LTD.: COMPANY SNAPSHOT
FIGURE 34 WOCKHARDT LIMITED: COMPANY SNAPSHOT
FIGURE 35 YPSOMED AG.: COMPANY SNAPSHOT
FAQ
The human insulin market size had crossed USD 23.05 Billion in 2020 and will observe a CAGR of more than 6.14% up to 2029.
The rise in the number of people with diabetes, increased exposure to diabetes risk factors, rising demand for human insulin analogues, technological developments in the field of human insulin delivery devices, and attractive medical reimbursements are all contributing factors to the market’s growth.
The region’s largest share is in North America. Products manufactured in nations like US and Canada that perform similarly and are inexpensively accessible to the general public have led to the increasing appeal.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.